2006. Implementation of the T2 Biosystems T2Bacteria Panel in a Level-One Trauma Center, Safety Net Hospital
Session: Poster Abstract Session: Diagnostics: Bacteria and Mycobacteria
Saturday, October 6, 2018
Room: S Poster Hall
  • ID Week Poster_CR Draft 3_COHENMODS - final poster.pdf (908.7 kB)
  • Background: Rapid detection and identification of sepsis causing pathogens are critical for optimizing antimicrobial therapy to improve patient survival and reduce healthcare costs. The T2Bacteria Panel RUO is a molecular diagnostic allowing detection of gram negative Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii and gram positive Staphylococcus aureus and Enterococcus faecium within a few hours. The purpose of our study was to determine the feasibility and efficacy of the T2Bacterial Panel RUO in an Emergency Medicine (ED) and Surgical Intensive Care Unit (SICU) setting.

    Methods: An IRB-approved, prospective, observational study was implemented at a Safety-Net, Level One Trauma Center in Denver, Colorado. Patients were enrolled who received an order for a blood culture from the ED or SICU. Patients who had blood drawn for cultures had a concurrent draw for testing with a T2Bacteria Panel RUO.

    Results: 66 patients are included in the present interim analysis. Mean patient age was 51 years old (19-84), 36% were female, 86% Caucasian (34% Hispanic/Latino), and 74% of patients were enrolled upon presentation to the ED, 13% from the SICU, and 15% from the wards. 90% of blood sampling (culture and T2Bacteria) was done from peripheral stick while 7% were from the initial stick of a peripheral IV and 2% obtained from an indwelling catheter.

    85% of blood cultures were negative. Of the 56 patients with negative blood culture, 53 had concordant negative T2Bacteria results, providing a specificity of 94.6%. 10 patients had positive blood cultures (15%) for T2Bacteria Panel RUO targets. Interestingly, only 5 of these (50%) had concordant positive T2Bacteria testing. Examining the discordant samples, all (5) blood culture positive, T2Bacteria negative were found to have clinically false positive blood cultures. T2Bacteria positive samples were distributed as follows: 2 E.coli, 1 S. aureus, 1 K. pneumoniae, and 1 P. aeruginosa. No detections were made for E. faecium or A. baumannii.

    Conclusion: In this interim analysis, T2Bacteria Panel RUO provides feasible rapid diagnostics for ED and surgical ICU settings with a high specificity and much shorter time to result when compared to gold standard blood cultures.

    Caitlin Robinson, BS1, Rebecca Jackson, MS1, Angela Sauaia, MD, PhD1,2 and Mitchell Cohen, MD1,3, (1)Surgery, Denver Health and Hospital Authority, Denver, CO, (2)Public Health & Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, (3)Biomedical Informatics and Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO


    C. Robinson, T2 Biosystems: Research Coordinator for funded study from T2 Biosystems , Research support .

    R. Jackson, T2 Biosystems: Research Assistant for funded study from T2 Biosystems , Research support .

    A. Sauaia, None

    M. Cohen, T2 Biosystems: PI on study being funded by T2 Biosystems, not paying for any part of salary , Research support .

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.